miRagen Therapeutics

microRNA Based Therapeutics

Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Current Investors
  • Pipeline
    • Pipeline
    • Areas of Focus
  • Partnerships
    • Partnerships Overview
    • Pharma Partnerships
    • Technology Partnerships
  • Technology
    • Our Platform
    • What are microRNAs?
    • Areas of Focus
    • Publications
  • Culture
    • Overview
    • Mission, Vision, Values
    • Careers
  • News

Publications:

2013

Year: 2013 2012 2011 2010 2009 2008 2007 2006

Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure

Eur J Heart Failure, View »
Share/Bookmark
  @miRagenRx twitter feed
June 11, 2013 - miRagen adds industry veterans to leadership team http://t.co/VRPUda4B6f
June 05, 2013 - Check out miRagen’s new website! http://t.co/ft06auGMOd
May 23, 2013 - Servier adds a new microRNA program under its strategic alliance with miRagen, triggering the first milestone http://t.co/vkggLHreV1
Copyright © 2013 miRagen Therapeutics
  • Home
  • Privacy Policy
  • Site Map
  • Contact
  • Careers
Site by Mentus